Explore how combining BTK inhibitors with CAR T-cell therapy enhances treatment efficacy for B-cell malignancies while managing potential toxicities.
Charlene Kabel, PharmD, BCOP
Advertisement
Charlene Kabel, PharmD, BCOP
Barnes-Jewish Hospital
Articles by Charlene Kabel, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Diuretics, eGFR, and Intensive BP Lowering in CKD: What to Watch
3
Finerenone in Heart Failure: Evidence and Practice a Year Later
4
Researchers Target Viral Fusion for Universal Flu, HIV Vaccines
5